Valuation : Organoidsciences Ltd.

Market Cap 44.59B 33.11M 28.48M 26.78M 24.45M 45.73M 3.13B 45.88M 318M 123M 1.6B 124M 122M 5.11B P/E 2024 *
-
P/E 2025 -15.2x
Enterprise Value 33.02B 24.53M 21.09M 19.84M 18.11M 33.87M 2.32B 33.98M 235M 90.92M 1.19B 92.11M 90.09M 3.78B EV / Sales 2024 *
-
EV / Sales 2025 99.9x
Free-Float
57.27%
Yield 2024 *
-
Yield 2025 -
1 day+2.11%
1 week-3.01%
Current month-3.01%
1 month-18.14%
3 months-46.06%
6 months-76.20%
Current year-82.32%
1 week 6,300
Extreme 6300
7,050
1 month 6,300
Extreme 6300
9,000
Current year 6,070
Extreme 6070
39,200
1 year 6,070
Extreme 6070
48,500
3 years 6,070
Extreme 6070
52,000
5 years 6,070
Extreme 6070
52,000
10 years 6,070
Extreme 6070
52,000
Manager TitleAgeSince
Chief Executive Officer 46 -
Chief Executive Officer 62 02/01/2026
Chief Tech/Sci/R&D Officer 41 -
Director TitleAgeSince
Director/Board Member 46 -
Director/Board Member 41 -
Director/Board Member - 27/03/2025
Date Insider Type Main position Quantity % Market Cap. Importance
5/14/25 A Others

Chief Executive Officer

1,670,000 -
5/14/25 A Others 30,000 --
Change 5-day change 1-year change 3-year change Capi.($)
+2.11%-3.01%-81.99% - 33.11M
-0.21%-3.29%-2.00%+15.50% 48.41B
-0.40%+2.16%+418.57%+554.47% 45.01B
-1.42%+2.52%+42.67%+22.27% 44.07B
-1.22%-0.37%+4.82%+84.42% 40.73B
-0.96%-1.38%+15.75%+45.91% 33.21B
-0.21%+2.86% - - 17.77B
-0.35%-0.45%+21.42%+117.63% 16.5B
-0.34%-0.28%+11.64%+31.71% 14.45B
-1.65%+0.09%+75.93%+41.15% 13.77B
Average -0.46%+0.04%+56.31%+114.13% 27.4B
Weighted average by Cap. -0.76%-0.02%+89.42%+135.15%

Financials

2024 2025
Net sales 1.95B 1.45M 1.25M 1.17M 1.07M 2M 137M 2.01M 13.91M 5.38M 70.26M 5.45M 5.33M 224M 2.41B 1.79M 1.54M 1.45M 1.32M 2.47M 169M 2.48M 17.14M 6.63M 86.56M 6.71M 6.57M 276M
Net income -11.25B -8.35M -7.18M -6.76M -6.17M -11.53M -790M -11.57M -80.11M -30.96M -405M -31.37M -30.68M -1.29B -15.37B -11.41M -9.82M -9.23M -8.43M -15.76M -1.08B -15.81M -109M -42.31M -553M -42.86M -41.93M -1.76B
Net Debt -8.11B -6.02M -5.18M -4.87M -4.45M -8.31M -569M -8.34M -57.75M -22.32M -292M -22.61M -22.12M -929M -11.56B -8.59M -7.38M -6.95M -6.34M -11.86M -812M -11.9M -82.35M -31.83M -416M -32.25M -31.54M -1.32B
Logo Organoidsciences Ltd.
OrganoidSciences Ltd is a Korea-based company primarily engaged in the development of regenerative therapies and provision of new material evaluation solutions. The Company primarily provides an organoid-based new material evaluation solution under the name of ODISEI to predict the effects of various new materials such as new drugs, foods and cosmetics when applied to the human body. In addition, the Company develops organoid-based regenerative therapies that directly regenerate tissues by engrafting on damaged areas. The Company is also engaged in the sale of intestinal organoid therapeutics, salivary gland organoid regenerative therapeutics, and other research reagents.
Employees
-
Date Price Change Volume
07/09/26 ₩6,770.00 +2.11% 17,429
04/09/26 ₩6,630.00 +1.22% 31,831
03/09/26 ₩6,550.00 +0.46% 26,212
02/09/26 ₩6,520.00 -5.78% 26,643
01/09/26 ₩6,920.00 -0.86% 14,953
  1. Stock Market
  2. Stocks
  3. A476040 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!